---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-103068"
form_type: "8-K"
ticker: "INMB"
cik: "0001711754"
company_name: "Inmune Bio, Inc."
filed_at: "2025-10-28T23:59:59+00:00"
generated_at: "2026-05-17T01:57:23.293768+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# INmune Bio to host Q3 2025 results conference call on October 30, 2025

## Summary
- Company will report Q3 2025 financial results and provide corporate update on October 30, 2025 at 4:30 PM ET.
- Dial-in details: 1-800-225-9448 (US), 1-203-518-9708 (international), Conference ID: INMUNE.
- Webcast accessible via provided link; replay available through Nov 13 by dialing 1-844-512-2921 (PIN 11159914).
- No financial results disclosed in this press release; results will be provided during the call.

## SEC filing metadata
- accession: 0001213900-25-103068
- form_type: 8-K
- ticker: INMB
- cik: 0001711754
- company_name: Inmune Bio, Inc.
- filed_at: 2025-10-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711754/000121390025103068/0001213900-25-103068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711754/000121390025103068/ea0262255-8k_inmune.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-103068
- JSON: https://secwatch.observer/filing/0001213900-25-103068.json
- Plain text: https://secwatch.observer/filing/0001213900-25-103068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.